Analyst Activity – William Blair Initiates Coverage On Pieris Pharmaceuticals (NASDAQ:PIRS) With a Outperform

ME Staff
-
0

Analyst Ratings For Pieris Pharmaceuticals (NASDAQ:PIRS)

Today, William Blair initiated coverage on Pieris Pharmaceuticals (NASDAQ:PIRS) with a Outperform.

Some recent analyst ratings include

  • 1/17/2018-William Blair initiated coverage with a Outperform rating.
  • 5/30/2017-Rodman & Renshaw initiated coverage with a Buy rating.
  • 9/28/2016-Roth Capital Reiterated Rating of Buy.

Recent Insider Trading Activity For Pieris Pharmaceuticals (NASDAQ:PIRS)
Pieris Pharmaceuticals (NASDAQ:PIRS) has insider ownership of 4.05% and institutional ownership of 50.45%.

  • On 1/3/2018 Orbimed Advisors Llc, Major Shareholder, sold 1,709,620 with an average share price of $7.35 per share and the total transaction amounting to $12,565,707.00.
  • On 12/18/2017 Orbimed Advisors Llc, Major Shareholder, sold 147,635 with an average share price of $5.70 per share and the total transaction amounting to $841,519.50.
  • On 8/17/2017 Allan Reine, Insider, bought 65,000 with an average share price of $4.82 per share and the total transaction amounting to $313,300.00.
  • On 8/17/2017 James A Geraghty, Director, bought 10,000 with an average share price of $4.82 per share and the total transaction amounting to $48,200.00.
  • On 6/14/2016 Louis Matis, SVP, bought 10,000 with an average share price of $1.70 per share and the total transaction amounting to $17,000.00.
  • On 6/13/2016 Darlene M Deptula-Hicks, CFO, bought 5,000 with an average share price of $1.66 per share and the total transaction amounting to $8,300.00.
  • On 6/13/2016 Stephen S Yoder, CEO, bought 6,000 with an average share price of $1.68 per share and the total transaction amounting to $10,080.00.

Recent Trading Activity for Pieris Pharmaceuticals (NASDAQ:PIRS)
Shares of Pieris Pharmaceuticals closed the previous trading session at 7.41 up +0.49 7.08% with 7.150000095367432 shares trading hands.